Stemcell United (SCU) Stock Price, News & Analysis

Company Overview

Stemcell United Limited, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, Greater China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as On Q Group Limited and changed its name to Stemcell United Limited in September 2015. Stemcell United Limited was incorporated in 1984 and is headquartered in Sydney, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$3.85 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Trading
• Current Symbol: ASX:SCU
• CIK: N/A
• Web: www.scu.com.sg
• Phone: 61-2-8072-1400
• Fax: N/A
• Employees: 340
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$3.77 million
• Net Margins: -19.91%
• Pretax Margin: N/A
• Return on Equity: -66.48%
• Return on Assets: -25.96%

Debt

• Debt-to-Equity Ratio: 41.12
• Current Ratio: 2.11
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: A$13.88 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,140,000,000
• Free Float: N/A
• Market Cap: A$3.85 million
• Optionable: Not Optionable
• Beta: 0.56